Chen Schor's Net Worth
$14.3 Million
Who is Chen Schor?
Chen Schor has an estimated net worth of $14.3 Million. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., SYNTA PHARMACEUTICALS CORP, Karyopharm Therapeutics Inc., BRAINSTORM CELL THERAPEUTICS INC., and EPIX Pharmaceuticals, Inc..
SEC CIK
Chen Schor's CIK is 0001340875
Past Insider Trading and Trends
2023 was Chen Schor's most active year for acquiring shares with 11 total transactions. Chen Schor's most active month to acquire stocks was the month of July. 2021 was Chen Schor's most active year for disposing of shares, totalling 33 transactions. Chen Schor's most active month to dispose stocks was the month of February. 2007 saw Chen Schor paying a total of $49,369.32 for 52,842 shares, this is the most they've acquired in one year. In 2022 Chen Schor cashed out on 313,208 shares for a total of $4,417,663.68, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adicet Bio, Inc. (ACET) Snapshot price: $3.195
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +35.78% | 55.01K |
$2.40 | -$36,696.00 | 208.77K |
Jan 24
| |||
Form 4
| -10.53% | -23.21K |
$1.39 | -$31,935.76 | 197.23K |
Sep 28 - Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
| +93.47% | 85.5K |
—
|
—
| 176.97K |
Jan 24
| |||
Form 4
| -21.62% | -39.95K |
$20.55 | -$811,241.79 | 144.89K |
Scheduled
|
Nov 10
| ||
Form 4
| -26.45% | -30.00K |
$19.05 | -$571,488.00 | 83.42K |
Scheduled
|
Nov 7
| ||
Form 4
| -18.25% | -25.31K |
$18.04 | -$456,718.33 | 113.42K |
Scheduled
|
Nov 2 - Nov 3
| ||
Form 4
| -17.35% | -21.29K |
$14.22 | -$302,715.36 | 101.42K |
Oct 4
| |||
Form 4
| -0.68% | -952.00 |
$18.00 | -$17,136.00 | 138.74K |
Scheduled
|
Sep 14
| ||
Form 4
| -35.95% | -78.41K |
$17.38 | -$1,317,221.72 | 139.69K |
Scheduled
|
Sep 9 - Sep 13
| ||
Form 4
| +11.16% | 26.71K |
$18.25 | -$388,506.00 | 265.97K |
Jul 6 - Aug 4
| |||
Form 4
| +21.77% | 26.71K |
$14.27 | -$303,779.76 | 149.42K |
Feb 14
| |||
Form 4
| +27.83% | 26.71K |
$11.69 | -$248,856.72 | 122.71K |
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
∞
| 240K |
—
|
—
| 240K |
Oct 1
| |||
Form 4
| -9.09% | -16.47K |
$10.53 | -$173,442.97 | 164.68K |
Scheduled
|
Jun 16
| ||
Form 4
| -8.33% | -16.47K |
$12.06 | -$198,499.28 | 181.14K |
Scheduled
|
Jun 3
| ||
Form 4
| -7.69% | -16.47K |
$13.45 | -$221,435.96 | 197.61K |
Scheduled
|
May 19
| ||
Form 4
| -7.14% | -16.47K |
$14.22 | -$234,221.96 | 214.07K |
Scheduled
|
May 5
| ||
Form 4
| -6.67% | -16.47K |
$12.01 | -$197,675.98 | 230.54K |
Scheduled
|
Apr 20
| ||
Form 4
| -6.25% | -16.47K |
$13.04 | -$214,700.18 | 247.01K |
Scheduled
|
Apr 6
| ||
Form 4
| -2.98% | -16.47K |
$12.76 | -$211,639.80 | 536.85K |
Scheduled
|
Mar 30
| ||
Form 4/A
| -19.35% | -135.39K |
$15.36 | -$252,558.18 | 564.48K |
Scheduled
|
Jan 22 - Mar 16
| ||
Form 4/A
| -24.91% | -8.65K |
—
|
—
| 26.07K |
Oct 23
| |||
Form 4
| -2.83% | -16.47K |
$15.36 | -$252,558.18 | 564.48K |
Scheduled
|
Mar 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 4
| -10.66% | -8.65K |
—
|
—
| 72.5K |
Oct 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 4
| +105.85% | 344K |
—
|
—
| 669K |
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| -50.27% | -2.24M |
—
|
—
| 2.21M |
Jul 6 - Nov 5
| |||
Form 4
| +0.11% | 2K |
$8.95 | $17,906.60 | 1.89M |
Apr 16
| |||
Form 4
| +0.11% | 2K |
$9.36 | $18,724.20 | 1.89M |
Apr 11
| |||
Form 4
| +0.11% | 2K |
$8.46 | $16,914.80 | 1.89M |
Apr 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SYNTA PHARMACEUTICALS CORP (MDGL) Snapshot price: $188.3701
Former President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +333.77% | 28.61K |
$9.48 | -$135,090.00 | 37.18K |
Jul 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
| +100.00% | 150K |
—
|
—
| 300K |
Jun 5
| |||
Form 4
|
∞
| 150K |
—
|
—
| 150K |
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Karyopharm Therapeutics Inc. (KPTI) Snapshot price: $1.515
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Snapshot price: $0.3717
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 125.56K |
Oct 24
| |||
Form 4
| +1.62% | 2K |
—
|
—
| 125.56K |
Nov 30
| |||
Form 4
| +1.65% | 2K |
—
|
—
| 123.56K |
Nov 10
| |||
Form 4
| +97.47% | 60K |
—
|
—
| 121.56K |
May 3
| |||
Form 4/A
|
∞
| 923.37K |
—
|
—
| 923.37K |
Oct 21
| |||
Form 4
|
∞
| 923.37K |
—
|
—
| 923.37K |
Aug 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EPIX Pharmaceuticals, Inc. No price found
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.89% | 5.46K |
$0.46 | -$1,515.24 | 145.72K |
Feb 25
| |||
Form 4
| +36.22% | 37.3K |
$1.03 | -$27,195.09 | 140.26K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
| +18.44% | 16.03K |
$3.08 | $49,369.32 | 102.97K |
Oct 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
| +3.57% | 3K |
$0.98 | $2,940.00 | 86.94K |
Nov 28
| |||
Form 4
| +21.76% | 15K |
$0.98 | $14,700.00 | 83.94K |
Nov 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 4
|
∞
| 68.94K |
—
|
—
| 68.94K |
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||